Potentiation of β-amyloid polymerisation by low-density lipoprotein enhances the peptide's vasoactivity

Biochimica et Biophysica Acta - General Subjects

Volumn 1670, Issue 2, 2004, Pages 147-155

  Stanyer, Lee ^a   Betteridge, D John ^a   Smith, Christopher C T ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

Aortic ring; Endothelial cell; Fibrillogenesis; Low density lipoprotein; Oxidation; Amyloid

Indexed keywords

ALKADIENE; AMYLOID BETA PROTEIN; LOW DENSITY LIPOPROTEIN; NORADRENALIN; PEPTIDE; STATIN; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ANTIOXIDANT ACTIVITY; ARTICLE; BETA SHEET; BLOOD VESSEL REACTIVITY; ENDOTHELIUM CELL; FIBER; HUMAN; LIPOPROTEIN BLOOD LEVEL; OXIDATION; POLYMERIZATION; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN STRUCTURE; VASCULAR RING;

EID: 1642491758     PISSN: 03044165     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbagen.2003.11.005     Document Type: Article

References (45)

1. Hardy J., Allsop D. Amyloid deposition as the central event in the aetiology of Alzheimer's disease. Trends Pharmacol. Sci. 12:1991;383-388.
2. Chen M., Inestrosa N.C., Ross G.S., Fernandez H.L. Platelets are the primary source of amyloid beta-peptide in human blood. Biochem. Biophys. Res. Commun. 213:1995;96-103.
3. Seubert P., Vigo-Pelfrey C., Esch F., Lee M., Dovey H., Davis D., Sinha S., Schlossmacher M., Whaley J., Swindlehurst C., McCormack R., Wolfert R., Selkoe D., Lieberburg I., Schenk D. Isolation and quantification of soluble Alzheimer's beta-peptide from biological fluids. Nature. 359:1992;325-327.
4. Smith C.C.T. Stimulated release of the β-amyloid protein of Alzheimer's disease by normal human platelets. Neurosci. Lett. 235:1997;157-159.
5. Smith C.C.T., Hyatt P.J., Stanyer L., Betteridge D.J. Platelet secretion of β-amyloid is increased in hypercholesterolaemia. Brain Res. 896:2001;161-164.
6. Sparks D.L. Coronary artery disease, hypertension, ApoE, and cholesterol: a link to Alzheimer's disease? Ann. N.Y. Acad. Sci. 826:1997;128-146.
7. Markesbury W.R. Oxidative stress hypothesis in Alzheimer's disease. Free Radic. Biol. Med. 23:1997;134-147.
8. Soto C., Sigurdsson E.M., Morelli L., Kumar R.A., Castano E.M., Frangione B. β-sheet breaker peptides inhibit fibrillogenesis in a rat brain model of amyloidosis: implications for Alzheimer's therapy. Nat. Med. 4:1998;822-826.
9. Blanc E.M., Toborek M., Mark R.J., Hennig B., Mattson M.P. Amyloid β-peptide induces cell monolayer albumin permeability, impairs glucose transport and induces apoptosis in vascular endothelial cells. J. Neurochem. 68:1997;1870-1881.
10. Davis-Salinas J., Saporito-Irwin S.M., Cotman C.W., Van Nostrand W.E. Amyloid beta-protein induces its own production in cultured degenerating cerebrovascular smooth muscle cells. J. Neurochem. 65:1995;319-334.
11. 1-42 induced endothelial toxicity. Brain Res. 762:1997;144-152.
12. Sutton E.T., Hellerman G.R., Thomas T. β-Amyloid-induced endothelial necrosis and inhibition of nitric oxide production. Exp. Cell Res. 230:1997;368-376.
13. Haas A.L., Siepmann T.J. Pathways of ubiquitin conjugation. FASEB J. 11:1997;1257-1268.
14. Kornitzer D., Ciechanover A. Modes of regulation of ubiquitin-mediated protein degradation. J. Cell. Physiol. 182:2000;1-11.
15. Pickart C.M. Targeting of substrates to the 26S proteasome. FASEB J. 11:1997;1055-1066.
16. Checler F., da Costa C.A., Ancolio K., Chevallier N., Lopez-Perez E., Maramband P. Role of the proteasome in Alzheimer's disease. Biochim. Biophys. Acta. 1502:2000;133-138.
17. Gregori L., Fuchs C., Figueiredo-Pereira M.E., Van Nostrand W.E., Goldgaber D. Amyloid beta-protein inhibits ubiquitin-dependent protein degradation in vitro. J. Biol. Chem. 270:1995;19702-19708.
18. Vieira O., Escargueil-Blanc I., Jurgens G., Borner C., Almeida L., Salvayre R., Negre-Salvayre A. Oxidised LDLs alter the activity of the ubiquitin-proteasome pathway: potential role in oxidised LDL-induced apoptosis. FASEB J. 14:2000;533-542.
19. Thomas T., Thomas G., McLendon C., Sutton T., Mullan M. β-Amyloid-mediated vasoactivity and vascular endothelial damage. Nature. 380:1996;168-171.
20. Hatch F.T., Lees R.S. Practical methods for plasma lipoprotein analysis. Adv. Lipid Res. 6:1968;1-68.
21. Stanyer L., Betteridge D.J., Smith C.C.T. An investigation into the mechanisms mediating plasma lipoprotein-potentiated β-amyloid fibrillogenesis. FEBS Lett. 518:2002;72-78.
22. Kosugi K., Morel D.W., DiCorleto P.E., Chisholm G.M. Toxicity of oxidised low-density lipoprotein to cultured fibroblasts is selective for S phase of the cell cycle. J. Cell. Physiol. 130:1987;311-320.
23. Wang C., Smith R.L. Lowry determination of protein in the presence of Triton X-100. Anal. Biochem. 63:1975;414-417.
24. Schuh J., Fairclough G.F., Haschmeyer R.H. Oxygen mediated heterogeneity of apo-low-density lipoprotein. Proc. Natl. Acad. Sci. U. S. A. 75:1978;3173-3177.
25. Corongui F.P., Banni S. Detection of conjugated dienes by second derivative ultraviolet spectrophotometry. Methods Enzymol. 233:1994;303-310.
26. Naiki H., Higuchi K., Hosokawa M., Takeda T. Fluorimetric determination of amyloid fibrils in vitro using the fluorescent dye, thioflavin T. Anal. Biochem. 177:1989;244-249.
27. Behl C., Davis J.B., Lesley R., Schubert D. Hydrogen peroxide mediates beta amyloid protein toxicity. Cell. 77:1994;817-827.
28. Amador E., Dorfman L.E., Wacker W.E.C. Serum lactic dehydrogenase: an analytical assessment of current assays. Clin. Chem. 9:1963;391-394.
29. Qiu J.H., Asai A., Chi S., Saito N., Hamada H., Kirino T. Proteasome inhibitors induce cytochrome c-caspase-3-like protease-mediated apoptosis in cultured cortical neurons. J. Neurosci. 20:2000;259-265.
30. Figueiredo-Pereira M.E., Berg K.A., Wilk S. A new inhibitor of the chymotrypsin-like activity of the multicatalytic proteinase complex (20S proteasome) induces accumulation of ubiquitin-protein conjugates in a neuronal cell. J. Neurochem. 63:1994;1578-1581.
31. Thomas T., McLendon C., Sutton E.T., Thomas G. Cerebrovascular endothelial dysfunction mediated by β-amyloid. NeuroReport. 8:1997;1387-1391.
32. Wisniewski H.M., Wegeil J., Wang K.C., Lech B. Ultrastructural studies of the cells forming amyloid in the cortical vessel wall in Alzheimer's disease. Acta Neuropathol. 84:1992;117-127.
33. Martel C.L., Mackic J.B., McComb J.G., Ghiso J., Zlokovic B.V. Blood-brain barrier uptake of the 40 and 42 amino acid sequences of circulating Alzheimer's amyloid-beta in guinea pigs. Neurosci. Lett. 206:1996;157-160.
34. Su G.C., Arendash G.W., Kalaria R.N., Bjugstad K.B., Mullan M. Intravascular infusions of soluble beta-amyloid compromise the blood-brain barrier, activate CNS glial cells and induce peripheral hemorrhage. Brain Res. 818:1999;105-117.
35. Masters C.L., Simms G., Weinman A., Multhaup G., McDonald B.L., Beyreuther K. Amyloid plaque core protein in Alzheimer's disease and Down's syndrome. Proc. Nat. Acad. Sci. U. S. A. 82:1985;4245-4249.
36. Li Q.-X., Whyte S., Tanner J.E., Evin G., Beyreuther K., Masters C.L. Secretion of Alzheimer's disease Aβ amyloid peptide by activated human platelets. Lab. Invest. 78:1998;461-469.
37. Biere A.L., Ostaszewski B., Stimson E.R., Hyman B.T., Magio J.E., Selkoe D.J. Amyloid β-peptide is transported on lipoproteins and albumin in human plasma. J. Biol. Chem. 271:1996;32916-32922.
38. Kuo Y.M., Emmerling M.R., Bisgaier C.L., Essenburg A.D., Lampert H.C., Drumm D., Roher A.E. Elevated low-density lipoprotein in Alzheimer's disease correlates with brain A-beta 1-42 levels. Biochem. Biophys. Res. Commun. 252:1998;711-715.
39. Refolo L.M., Pappolla M.A., Malester B., La Francois J., Bryant-Thomas T., Wang R., Tint G.S., Sambaburti K., Duff K. Hypercholesterolaemia accelerates the Alzheimer's amyloid pathology in a transgenic mouse model. Neurobiol. Dis. 7:2000;321-331.
40. Sparks D.L., Scheff S.W., Hunsaker J.C., Liu H., Landers T., Gross D.R. Induction of Alzheimer-like β-amyloid immunoreactivity in the brains of rabbits with dietary cholesterol. Exp. Neurol. 126:1994;88-94.
41. Nourooz-Zadeh J., Smith C.C.T., Betteridge D.J. Measures of oxidative stress in heterozygous familial hypercholesterolaemia. Atherosclerosis. 156:2001;435-441.
42. Hyman B.T., Strickland D., Rebeck W. Role of the low-density lipoprotein receptor-related protein in β-amyloid metabolism and Alzheimer's disease. Arch. Neurol. 57:2000;646-650.
43. Yan S.D., Roher A., Chaney M., Zlokovic B., Schmidt A.M., Stern D. Cellular cofactors potentiating induction of stress and cytotoxicity by amyloid β-peptide. Biochim. Biophys. Acta. 1502:2000;145-157.
44. Davis R.A. Cell and molecular biology of the assembly and secretion of apolipoprotein B-containing lipoproteins by the liver. Biochim. Biophys. Acta. 1440:1999;1-31.
45. Crawford F., Soto C., Suo Z., Fang C., Parker T., Sawar A., Frangione B., Mullan M. Alzheimer's beta-amyloid vasoactivity: identification of a novel conformational intermediate. FEBS Lett. 436:1998;445-448.